Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    EXOSTOSES, MULTIPLE, TYPE II
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)
Condition: HIV Infections
Interventions: Drug: raltegravir potassium;   Drug: Comparator: Placebo
2 Completed A Dose-Range Finding Study in Patient With Type 2 Diabetes (MK-3102-006 EXT1[AM3])
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: MK-3102;   Drug: Placebo;   Drug: pioglitazone;   Drug: metformin
3 Terminated
Has Results
Dose Range Finding Study of MK-0941 in Patients With Type 2 Diabetes Mellitus on Insulin (MK-0941-007 AM3 EXT1 AM1)(TERMINATED)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: MK-0941;   Drug: Comparator: Placebo;   Biological: Lantus;   Drug: Metformin

Indicates status has not been verified in more than two years